U.S. market Closed. Opens in 9 hours 58 minutes

TMCI | Treace Medical Concepts, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 4.73 - 5.58
52 Week Range 3.92 - 15.98
Beta 0.40
Implied Volatility 124.49%
IV Rank 54.49%
Day's Volume 1,112,952
Average Volume 600,526
Shares Outstanding 62,190,400
Market Cap 337,693,872
Sector Healthcare
Industry Medical - Devices
IPO Date 2021-04-23
Valuation
Profitability
Growth
Health
P/E Ratio -5.32
Forward P/E Ratio N/A
EPS -1.02
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 516
Country USA
Website TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
*Chart delayed
Analyzing fundamentals for TMCI we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see TMCI Fundamentals page.

Watching at TMCI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on TMCI Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙